nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Capecitabine—colon cancer	0.183	0.441	CbGbCtD
Dolasetron—CYP2C9—Fluorouracil—colon cancer	0.108	0.262	CbGbCtD
Dolasetron—CYP3A4—Irinotecan—colon cancer	0.0656	0.159	CbGbCtD
Dolasetron—CYP3A4—Vincristine—colon cancer	0.0574	0.139	CbGbCtD
Dolasetron—HTR3A—myenteric nerve plexus—colon cancer	0.0495	0.765	CbGeAlD
Dolasetron—HTR3A—digestive system—colon cancer	0.00375	0.0579	CbGeAlD
Dolasetron—Thrombophlebitis—Capecitabine—colon cancer	0.00219	0.0042	CcSEcCtD
Dolasetron—Sleep disorder—Capecitabine—colon cancer	0.00219	0.0042	CcSEcCtD
Dolasetron—Stomatitis—Vincristine—colon cancer	0.00218	0.00419	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00218	0.00418	CcSEcCtD
Dolasetron—Hepatic function abnormal—Capecitabine—colon cancer	0.00217	0.00416	CcSEcCtD
Dolasetron—Polyuria—Capecitabine—colon cancer	0.00216	0.00414	CcSEcCtD
Dolasetron—Acute coronary syndrome—Irinotecan—colon cancer	0.00215	0.00413	CcSEcCtD
Dolasetron—Myocardial infarction—Irinotecan—colon cancer	0.00214	0.0041	CcSEcCtD
Dolasetron—Hyperbilirubinaemia—Methotrexate—colon cancer	0.00214	0.0041	CcSEcCtD
Dolasetron—Stomatitis—Irinotecan—colon cancer	0.00213	0.00408	CcSEcCtD
Dolasetron—Jaundice—Irinotecan—colon cancer	0.00213	0.00408	CcSEcCtD
Dolasetron—Vascular purpura—Capecitabine—colon cancer	0.00212	0.00407	CcSEcCtD
Dolasetron—Oliguria—Methotrexate—colon cancer	0.00211	0.00405	CcSEcCtD
Dolasetron—Pneumonia—Fluorouracil—colon cancer	0.0021	0.00403	CcSEcCtD
Dolasetron—Acute coronary syndrome—Fluorouracil—colon cancer	0.00206	0.00395	CcSEcCtD
Dolasetron—Renal failure acute—Capecitabine—colon cancer	0.00205	0.00394	CcSEcCtD
Dolasetron—Myocardial infarction—Fluorouracil—colon cancer	0.00205	0.00393	CcSEcCtD
Dolasetron—Stomatitis—Fluorouracil—colon cancer	0.00204	0.00391	CcSEcCtD
Dolasetron—Increased appetite—Capecitabine—colon cancer	0.00202	0.00387	CcSEcCtD
Dolasetron—Bradycardia—Irinotecan—colon cancer	0.00199	0.00383	CcSEcCtD
Dolasetron—Epistaxis—Fluorouracil—colon cancer	0.00197	0.00378	CcSEcCtD
Dolasetron—Purpura—Capecitabine—colon cancer	0.00197	0.00377	CcSEcCtD
Dolasetron—Visual impairment—Irinotecan—colon cancer	0.00189	0.00362	CcSEcCtD
Dolasetron—CYP2C9—digestive system—colon cancer	0.00184	0.0284	CbGeAlD
Dolasetron—Face oedema—Capecitabine—colon cancer	0.00183	0.00351	CcSEcCtD
Dolasetron—Aplastic anaemia—Methotrexate—colon cancer	0.00183	0.0035	CcSEcCtD
Dolasetron—Flushing—Irinotecan—colon cancer	0.00182	0.00349	CcSEcCtD
Dolasetron—Cardiac arrest—Capecitabine—colon cancer	0.0018	0.00346	CcSEcCtD
Dolasetron—Urinary retention—Capecitabine—colon cancer	0.0018	0.00346	CcSEcCtD
Dolasetron—Ataxia—Capecitabine—colon cancer	0.00178	0.00342	CcSEcCtD
Dolasetron—Dehydration—Capecitabine—colon cancer	0.00176	0.00338	CcSEcCtD
Dolasetron—Chills—Irinotecan—colon cancer	0.00176	0.00337	CcSEcCtD
Dolasetron—Urine output increased—Methotrexate—colon cancer	0.00176	0.00337	CcSEcCtD
Dolasetron—Arrhythmia—Irinotecan—colon cancer	0.00175	0.00336	CcSEcCtD
Dolasetron—Orthostatic hypotension—Capecitabine—colon cancer	0.00173	0.00332	CcSEcCtD
Dolasetron—CYP3A4—renal system—colon cancer	0.00171	0.0264	CbGeAlD
Dolasetron—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00171	0.00327	CcSEcCtD
Dolasetron—Sepsis—Methotrexate—colon cancer	0.00169	0.00324	CcSEcCtD
Dolasetron—CYP2D6—renal system—colon cancer	0.00168	0.026	CbGeAlD
Dolasetron—Flatulence—Irinotecan—colon cancer	0.00168	0.00322	CcSEcCtD
Dolasetron—Arrhythmia—Fluorouracil—colon cancer	0.00168	0.00322	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00167	0.00321	CcSEcCtD
Dolasetron—Abdominal distension—Capecitabine—colon cancer	0.00165	0.00316	CcSEcCtD
Dolasetron—Thrombophlebitis—Methotrexate—colon cancer	0.00163	0.00313	CcSEcCtD
Dolasetron—Anaemia—Vincristine—colon cancer	0.00162	0.00311	CcSEcCtD
Dolasetron—Bronchospasm—Capecitabine—colon cancer	0.00161	0.00309	CcSEcCtD
Dolasetron—Agitation—Vincristine—colon cancer	0.00161	0.00309	CcSEcCtD
Dolasetron—Polyuria—Methotrexate—colon cancer	0.00161	0.00308	CcSEcCtD
Dolasetron—Sweating increased—Capecitabine—colon cancer	0.0016	0.00306	CcSEcCtD
Dolasetron—Ill-defined disorder—Irinotecan—colon cancer	0.00158	0.00304	CcSEcCtD
Dolasetron—Anaemia—Irinotecan—colon cancer	0.00158	0.00302	CcSEcCtD
Dolasetron—Vertigo—Vincristine—colon cancer	0.00157	0.00302	CcSEcCtD
Dolasetron—Malaise—Irinotecan—colon cancer	0.00154	0.00295	CcSEcCtD
Dolasetron—Vertigo—Irinotecan—colon cancer	0.00153	0.00294	CcSEcCtD
Dolasetron—Dysuria—Capecitabine—colon cancer	0.00153	0.00294	CcSEcCtD
Dolasetron—Syncope—Irinotecan—colon cancer	0.00153	0.00293	CcSEcCtD
Dolasetron—Renal failure acute—Methotrexate—colon cancer	0.00153	0.00293	CcSEcCtD
Dolasetron—Convulsion—Vincristine—colon cancer	0.00152	0.00291	CcSEcCtD
Dolasetron—Hypertension—Vincristine—colon cancer	0.00151	0.0029	CcSEcCtD
Dolasetron—Anaemia—Fluorouracil—colon cancer	0.00151	0.0029	CcSEcCtD
Dolasetron—Loss of consciousness—Irinotecan—colon cancer	0.0015	0.00288	CcSEcCtD
Dolasetron—Myalgia—Vincristine—colon cancer	0.00149	0.00286	CcSEcCtD
Dolasetron—Cough—Irinotecan—colon cancer	0.00149	0.00286	CcSEcCtD
Dolasetron—Hypertension—Irinotecan—colon cancer	0.00147	0.00283	CcSEcCtD
Dolasetron—Pneumonia—Capecitabine—colon cancer	0.00147	0.00282	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Methotrexate—colon cancer	0.00146	0.0028	CcSEcCtD
Dolasetron—Acute coronary syndrome—Capecitabine—colon cancer	0.00144	0.00276	CcSEcCtD
Dolasetron—Discomfort—Irinotecan—colon cancer	0.00143	0.00275	CcSEcCtD
Dolasetron—Myocardial infarction—Capecitabine—colon cancer	0.00143	0.00275	CcSEcCtD
Dolasetron—Anaphylactic shock—Vincristine—colon cancer	0.00143	0.00274	CcSEcCtD
Dolasetron—Oedema—Vincristine—colon cancer	0.00143	0.00274	CcSEcCtD
Dolasetron—Stomatitis—Capecitabine—colon cancer	0.00142	0.00273	CcSEcCtD
Dolasetron—Jaundice—Capecitabine—colon cancer	0.00142	0.00273	CcSEcCtD
Dolasetron—Convulsion—Fluorouracil—colon cancer	0.00142	0.00272	CcSEcCtD
Dolasetron—Confusional state—Irinotecan—colon cancer	0.0014	0.00269	CcSEcCtD
Dolasetron—CYP3A4—digestive system—colon cancer	0.0014	0.0216	CbGeAlD
Dolasetron—Thrombocytopenia—Vincristine—colon cancer	0.0014	0.00268	CcSEcCtD
Dolasetron—Haematuria—Capecitabine—colon cancer	0.00139	0.00267	CcSEcCtD
Dolasetron—Anaphylactic shock—Irinotecan—colon cancer	0.00139	0.00267	CcSEcCtD
Dolasetron—Oedema—Irinotecan—colon cancer	0.00139	0.00267	CcSEcCtD
Dolasetron—Chest pain—Fluorouracil—colon cancer	0.00139	0.00267	CcSEcCtD
Dolasetron—Myalgia—Fluorouracil—colon cancer	0.00139	0.00267	CcSEcCtD
Dolasetron—Hyperhidrosis—Vincristine—colon cancer	0.00138	0.00265	CcSEcCtD
Dolasetron—CYP2D6—digestive system—colon cancer	0.00138	0.0213	CbGeAlD
Dolasetron—Epistaxis—Capecitabine—colon cancer	0.00138	0.00264	CcSEcCtD
Dolasetron—Discomfort—Fluorouracil—colon cancer	0.00137	0.00264	CcSEcCtD
Dolasetron—Shock—Irinotecan—colon cancer	0.00137	0.00263	CcSEcCtD
Dolasetron—CYP2C9—liver—colon cancer	0.00137	0.0211	CbGeAlD
Dolasetron—Thrombocytopenia—Irinotecan—colon cancer	0.00136	0.00261	CcSEcCtD
Dolasetron—Anorexia—Vincristine—colon cancer	0.00136	0.00261	CcSEcCtD
Dolasetron—Hyperhidrosis—Irinotecan—colon cancer	0.00135	0.00258	CcSEcCtD
Dolasetron—Confusional state—Fluorouracil—colon cancer	0.00134	0.00258	CcSEcCtD
Dolasetron—Hypotension—Vincristine—colon cancer	0.00134	0.00256	CcSEcCtD
Dolasetron—Bradycardia—Capecitabine—colon cancer	0.00134	0.00256	CcSEcCtD
Dolasetron—Oedema—Fluorouracil—colon cancer	0.00133	0.00256	CcSEcCtD
Dolasetron—Anaphylactic shock—Fluorouracil—colon cancer	0.00133	0.00256	CcSEcCtD
Dolasetron—Anorexia—Irinotecan—colon cancer	0.00133	0.00255	CcSEcCtD
Dolasetron—Ataxia—Methotrexate—colon cancer	0.00133	0.00255	CcSEcCtD
Dolasetron—Thrombocytopenia—Fluorouracil—colon cancer	0.00131	0.0025	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Vincristine—colon cancer	0.0013	0.0025	CcSEcCtD
Dolasetron—Tachycardia—Fluorouracil—colon cancer	0.0013	0.0025	CcSEcCtD
Dolasetron—Hypotension—Irinotecan—colon cancer	0.0013	0.0025	CcSEcCtD
Dolasetron—Oedema peripheral—Capecitabine—colon cancer	0.00129	0.00248	CcSEcCtD
Dolasetron—Paraesthesia—Vincristine—colon cancer	0.00128	0.00246	CcSEcCtD
Dolasetron—Anorexia—Fluorouracil—colon cancer	0.00127	0.00244	CcSEcCtD
Dolasetron—Visual impairment—Capecitabine—colon cancer	0.00126	0.00242	CcSEcCtD
Dolasetron—Paraesthesia—Irinotecan—colon cancer	0.00125	0.0024	CcSEcCtD
Dolasetron—Hypotension—Fluorouracil—colon cancer	0.00125	0.00239	CcSEcCtD
Dolasetron—Decreased appetite—Vincristine—colon cancer	0.00124	0.00238	CcSEcCtD
Dolasetron—Dyspnoea—Irinotecan—colon cancer	0.00124	0.00238	CcSEcCtD
Dolasetron—Somnolence—Irinotecan—colon cancer	0.00124	0.00237	CcSEcCtD
Dolasetron—Fatigue—Vincristine—colon cancer	0.00123	0.00236	CcSEcCtD
Dolasetron—Dyspepsia—Irinotecan—colon cancer	0.00123	0.00235	CcSEcCtD
Dolasetron—Tinnitus—Capecitabine—colon cancer	0.00122	0.00235	CcSEcCtD
Dolasetron—Pain—Vincristine—colon cancer	0.00122	0.00234	CcSEcCtD
Dolasetron—Constipation—Vincristine—colon cancer	0.00122	0.00234	CcSEcCtD
Dolasetron—Flushing—Capecitabine—colon cancer	0.00122	0.00233	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00121	0.00233	CcSEcCtD
Dolasetron—Decreased appetite—Irinotecan—colon cancer	0.00121	0.00232	CcSEcCtD
Dolasetron—Fatigue—Irinotecan—colon cancer	0.0012	0.0023	CcSEcCtD
Dolasetron—Paraesthesia—Fluorouracil—colon cancer	0.0012	0.0023	CcSEcCtD
Dolasetron—Pancreatitis—Methotrexate—colon cancer	0.0012	0.00229	CcSEcCtD
Dolasetron—Pain—Irinotecan—colon cancer	0.00119	0.00228	CcSEcCtD
Dolasetron—Constipation—Irinotecan—colon cancer	0.00119	0.00228	CcSEcCtD
Dolasetron—Dyspnoea—Fluorouracil—colon cancer	0.00119	0.00228	CcSEcCtD
Dolasetron—Somnolence—Fluorouracil—colon cancer	0.00119	0.00227	CcSEcCtD
Dolasetron—Chills—Capecitabine—colon cancer	0.00118	0.00226	CcSEcCtD
Dolasetron—Dyspepsia—Fluorouracil—colon cancer	0.00117	0.00225	CcSEcCtD
Dolasetron—Arrhythmia—Capecitabine—colon cancer	0.00117	0.00225	CcSEcCtD
Dolasetron—Gastrointestinal pain—Vincristine—colon cancer	0.00117	0.00224	CcSEcCtD
Dolasetron—Decreased appetite—Fluorouracil—colon cancer	0.00116	0.00222	CcSEcCtD
Dolasetron—Feeling abnormal—Irinotecan—colon cancer	0.00115	0.0022	CcSEcCtD
Dolasetron—Dysuria—Methotrexate—colon cancer	0.00114	0.00219	CcSEcCtD
Dolasetron—Pain—Fluorouracil—colon cancer	0.00114	0.00219	CcSEcCtD
Dolasetron—Gastrointestinal pain—Irinotecan—colon cancer	0.00114	0.00218	CcSEcCtD
Dolasetron—Abdominal pain—Vincristine—colon cancer	0.00113	0.00217	CcSEcCtD
Dolasetron—Body temperature increased—Vincristine—colon cancer	0.00113	0.00217	CcSEcCtD
Dolasetron—Flatulence—Capecitabine—colon cancer	0.00112	0.00216	CcSEcCtD
Dolasetron—Dysgeusia—Capecitabine—colon cancer	0.00112	0.00214	CcSEcCtD
Dolasetron—Abdominal pain—Irinotecan—colon cancer	0.0011	0.00211	CcSEcCtD
Dolasetron—Body temperature increased—Irinotecan—colon cancer	0.0011	0.00211	CcSEcCtD
Dolasetron—Feeling abnormal—Fluorouracil—colon cancer	0.0011	0.00211	CcSEcCtD
Dolasetron—Pneumonia—Methotrexate—colon cancer	0.00109	0.0021	CcSEcCtD
Dolasetron—Drowsiness—Methotrexate—colon cancer	0.00109	0.00209	CcSEcCtD
Dolasetron—Tremor—Capecitabine—colon cancer	0.00107	0.00205	CcSEcCtD
Dolasetron—Stomatitis—Methotrexate—colon cancer	0.00106	0.00203	CcSEcCtD
Dolasetron—Ill-defined disorder—Capecitabine—colon cancer	0.00106	0.00203	CcSEcCtD
Dolasetron—Urticaria—Fluorouracil—colon cancer	0.00106	0.00203	CcSEcCtD
Dolasetron—Anaemia—Capecitabine—colon cancer	0.00106	0.00202	CcSEcCtD
Dolasetron—Body temperature increased—Fluorouracil—colon cancer	0.00105	0.00202	CcSEcCtD
Dolasetron—Hypersensitivity—Vincristine—colon cancer	0.00105	0.00202	CcSEcCtD
Dolasetron—CYP3A4—liver—colon cancer	0.00104	0.0161	CbGeAlD
Dolasetron—Haematuria—Methotrexate—colon cancer	0.00104	0.00199	CcSEcCtD
Dolasetron—Malaise—Capecitabine—colon cancer	0.00103	0.00197	CcSEcCtD
Dolasetron—CYP2D6—liver—colon cancer	0.00103	0.0159	CbGeAlD
Dolasetron—Epistaxis—Methotrexate—colon cancer	0.00103	0.00197	CcSEcCtD
Dolasetron—Vertigo—Capecitabine—colon cancer	0.00103	0.00197	CcSEcCtD
Dolasetron—Hypersensitivity—Irinotecan—colon cancer	0.00103	0.00197	CcSEcCtD
Dolasetron—Asthenia—Vincristine—colon cancer	0.00103	0.00197	CcSEcCtD
Dolasetron—Syncope—Capecitabine—colon cancer	0.00102	0.00196	CcSEcCtD
Dolasetron—Palpitations—Capecitabine—colon cancer	0.00101	0.00194	CcSEcCtD
Dolasetron—Loss of consciousness—Capecitabine—colon cancer	0.001	0.00192	CcSEcCtD
Dolasetron—Asthenia—Irinotecan—colon cancer	0.000999	0.00192	CcSEcCtD
Dolasetron—Cough—Capecitabine—colon cancer	0.000996	0.00191	CcSEcCtD
Dolasetron—Hypertension—Capecitabine—colon cancer	0.000986	0.00189	CcSEcCtD
Dolasetron—Hypersensitivity—Fluorouracil—colon cancer	0.000982	0.00188	CcSEcCtD
Dolasetron—Diarrhoea—Vincristine—colon cancer	0.000978	0.00188	CcSEcCtD
Dolasetron—Chest pain—Capecitabine—colon cancer	0.000972	0.00186	CcSEcCtD
Dolasetron—Arthralgia—Capecitabine—colon cancer	0.000972	0.00186	CcSEcCtD
Dolasetron—Myalgia—Capecitabine—colon cancer	0.000972	0.00186	CcSEcCtD
Dolasetron—Anxiety—Capecitabine—colon cancer	0.000969	0.00186	CcSEcCtD
Dolasetron—Discomfort—Capecitabine—colon cancer	0.00096	0.00184	CcSEcCtD
Dolasetron—Diarrhoea—Irinotecan—colon cancer	0.000953	0.00183	CcSEcCtD
Dolasetron—Dry mouth—Capecitabine—colon cancer	0.000951	0.00182	CcSEcCtD
Dolasetron—Dizziness—Vincristine—colon cancer	0.000945	0.00181	CcSEcCtD
Dolasetron—Pruritus—Fluorouracil—colon cancer	0.000943	0.00181	CcSEcCtD
Dolasetron—Visual impairment—Methotrexate—colon cancer	0.000941	0.0018	CcSEcCtD
Dolasetron—Confusional state—Capecitabine—colon cancer	0.000939	0.0018	CcSEcCtD
Dolasetron—Oedema—Capecitabine—colon cancer	0.000932	0.00179	CcSEcCtD
Dolasetron—Dizziness—Irinotecan—colon cancer	0.000921	0.00177	CcSEcCtD
Dolasetron—Shock—Capecitabine—colon cancer	0.000917	0.00176	CcSEcCtD
Dolasetron—Diarrhoea—Fluorouracil—colon cancer	0.000912	0.00175	CcSEcCtD
Dolasetron—Thrombocytopenia—Capecitabine—colon cancer	0.000912	0.00175	CcSEcCtD
Dolasetron—Tinnitus—Methotrexate—colon cancer	0.00091	0.00175	CcSEcCtD
Dolasetron—Tachycardia—Capecitabine—colon cancer	0.000909	0.00174	CcSEcCtD
Dolasetron—Rash—Vincristine—colon cancer	0.000901	0.00173	CcSEcCtD
Dolasetron—Hyperhidrosis—Capecitabine—colon cancer	0.000901	0.00173	CcSEcCtD
Dolasetron—Dermatitis—Vincristine—colon cancer	0.0009	0.00173	CcSEcCtD
Dolasetron—Headache—Vincristine—colon cancer	0.000896	0.00172	CcSEcCtD
Dolasetron—Anorexia—Capecitabine—colon cancer	0.000888	0.0017	CcSEcCtD
Dolasetron—Dizziness—Fluorouracil—colon cancer	0.000882	0.00169	CcSEcCtD
Dolasetron—Rash—Irinotecan—colon cancer	0.000878	0.00168	CcSEcCtD
Dolasetron—Dermatitis—Irinotecan—colon cancer	0.000877	0.00168	CcSEcCtD
Dolasetron—Chills—Methotrexate—colon cancer	0.000876	0.00168	CcSEcCtD
Dolasetron—Headache—Irinotecan—colon cancer	0.000872	0.00167	CcSEcCtD
Dolasetron—Hypotension—Capecitabine—colon cancer	0.000871	0.00167	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000849	0.00163	CcSEcCtD
Dolasetron—Rash—Fluorouracil—colon cancer	0.000841	0.00161	CcSEcCtD
Dolasetron—Dermatitis—Fluorouracil—colon cancer	0.00084	0.00161	CcSEcCtD
Dolasetron—Paraesthesia—Capecitabine—colon cancer	0.000837	0.0016	CcSEcCtD
Dolasetron—Headache—Fluorouracil—colon cancer	0.000835	0.0016	CcSEcCtD
Dolasetron—Dysgeusia—Methotrexate—colon cancer	0.000832	0.0016	CcSEcCtD
Dolasetron—Dyspnoea—Capecitabine—colon cancer	0.000831	0.00159	CcSEcCtD
Dolasetron—Dyspepsia—Capecitabine—colon cancer	0.00082	0.00157	CcSEcCtD
Dolasetron—Decreased appetite—Capecitabine—colon cancer	0.00081	0.00155	CcSEcCtD
Dolasetron—Fatigue—Capecitabine—colon cancer	0.000803	0.00154	CcSEcCtD
Dolasetron—Constipation—Capecitabine—colon cancer	0.000797	0.00153	CcSEcCtD
Dolasetron—Pain—Capecitabine—colon cancer	0.000797	0.00153	CcSEcCtD
Dolasetron—Ill-defined disorder—Methotrexate—colon cancer	0.000789	0.00151	CcSEcCtD
Dolasetron—Anaemia—Methotrexate—colon cancer	0.000786	0.00151	CcSEcCtD
Dolasetron—Feeling abnormal—Capecitabine—colon cancer	0.000768	0.00147	CcSEcCtD
Dolasetron—Malaise—Methotrexate—colon cancer	0.000766	0.00147	CcSEcCtD
Dolasetron—Vertigo—Methotrexate—colon cancer	0.000764	0.00146	CcSEcCtD
Dolasetron—Gastrointestinal pain—Capecitabine—colon cancer	0.000762	0.00146	CcSEcCtD
Dolasetron—Cough—Methotrexate—colon cancer	0.000742	0.00142	CcSEcCtD
Dolasetron—Urticaria—Capecitabine—colon cancer	0.00074	0.00142	CcSEcCtD
Dolasetron—Abdominal pain—Capecitabine—colon cancer	0.000737	0.00141	CcSEcCtD
Dolasetron—Body temperature increased—Capecitabine—colon cancer	0.000737	0.00141	CcSEcCtD
Dolasetron—Convulsion—Methotrexate—colon cancer	0.000736	0.00141	CcSEcCtD
Dolasetron—Arthralgia—Methotrexate—colon cancer	0.000724	0.00139	CcSEcCtD
Dolasetron—Myalgia—Methotrexate—colon cancer	0.000724	0.00139	CcSEcCtD
Dolasetron—Chest pain—Methotrexate—colon cancer	0.000724	0.00139	CcSEcCtD
Dolasetron—Discomfort—Methotrexate—colon cancer	0.000715	0.00137	CcSEcCtD
Dolasetron—Confusional state—Methotrexate—colon cancer	0.000699	0.00134	CcSEcCtD
Dolasetron—Anaphylactic shock—Methotrexate—colon cancer	0.000694	0.00133	CcSEcCtD
Dolasetron—Hypersensitivity—Capecitabine—colon cancer	0.000686	0.00132	CcSEcCtD
Dolasetron—Thrombocytopenia—Methotrexate—colon cancer	0.000679	0.0013	CcSEcCtD
Dolasetron—Hyperhidrosis—Methotrexate—colon cancer	0.000671	0.00129	CcSEcCtD
Dolasetron—Asthenia—Capecitabine—colon cancer	0.000669	0.00128	CcSEcCtD
Dolasetron—Anorexia—Methotrexate—colon cancer	0.000661	0.00127	CcSEcCtD
Dolasetron—Pruritus—Capecitabine—colon cancer	0.000659	0.00126	CcSEcCtD
Dolasetron—Hypotension—Methotrexate—colon cancer	0.000648	0.00124	CcSEcCtD
Dolasetron—Diarrhoea—Capecitabine—colon cancer	0.000638	0.00122	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000632	0.00121	CcSEcCtD
Dolasetron—Paraesthesia—Methotrexate—colon cancer	0.000623	0.00119	CcSEcCtD
Dolasetron—Dyspnoea—Methotrexate—colon cancer	0.000618	0.00119	CcSEcCtD
Dolasetron—Somnolence—Methotrexate—colon cancer	0.000617	0.00118	CcSEcCtD
Dolasetron—Dizziness—Capecitabine—colon cancer	0.000616	0.00118	CcSEcCtD
Dolasetron—Dyspepsia—Methotrexate—colon cancer	0.000611	0.00117	CcSEcCtD
Dolasetron—Decreased appetite—Methotrexate—colon cancer	0.000603	0.00116	CcSEcCtD
Dolasetron—Fatigue—Methotrexate—colon cancer	0.000598	0.00115	CcSEcCtD
Dolasetron—Pain—Methotrexate—colon cancer	0.000593	0.00114	CcSEcCtD
Dolasetron—Rash—Capecitabine—colon cancer	0.000587	0.00113	CcSEcCtD
Dolasetron—Dermatitis—Capecitabine—colon cancer	0.000587	0.00113	CcSEcCtD
Dolasetron—Headache—Capecitabine—colon cancer	0.000584	0.00112	CcSEcCtD
Dolasetron—Feeling abnormal—Methotrexate—colon cancer	0.000572	0.0011	CcSEcCtD
Dolasetron—Gastrointestinal pain—Methotrexate—colon cancer	0.000567	0.00109	CcSEcCtD
Dolasetron—Urticaria—Methotrexate—colon cancer	0.000551	0.00106	CcSEcCtD
Dolasetron—Abdominal pain—Methotrexate—colon cancer	0.000548	0.00105	CcSEcCtD
Dolasetron—Body temperature increased—Methotrexate—colon cancer	0.000548	0.00105	CcSEcCtD
Dolasetron—Hypersensitivity—Methotrexate—colon cancer	0.000511	0.00098	CcSEcCtD
Dolasetron—Asthenia—Methotrexate—colon cancer	0.000498	0.000955	CcSEcCtD
Dolasetron—Pruritus—Methotrexate—colon cancer	0.000491	0.000941	CcSEcCtD
Dolasetron—Diarrhoea—Methotrexate—colon cancer	0.000475	0.00091	CcSEcCtD
Dolasetron—Dizziness—Methotrexate—colon cancer	0.000459	0.00088	CcSEcCtD
Dolasetron—Rash—Methotrexate—colon cancer	0.000437	0.000839	CcSEcCtD
Dolasetron—Dermatitis—Methotrexate—colon cancer	0.000437	0.000838	CcSEcCtD
Dolasetron—Headache—Methotrexate—colon cancer	0.000435	0.000834	CcSEcCtD
